This list is an analysis based on recent market events. It's not an investment recommendation.
About
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
The current price of IVRN is $0 USD — it has decreased by -20% in the past 24 hours. Watch Innoveren Scientific stock price performance more closely on the chart.
What is Innoveren Scientific stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Innoveren Scientific stocks are traded under the ticker IVRN.
What is Innoveren Scientific market cap?▼
Today Innoveren Scientific has the market capitalization of 285.2
What is Innoveren Scientific revenue for the last year?▼
Innoveren Scientific revenue for the last year amounts to 906,000 USD.
What is Innoveren Scientific net income for the last year?▼
IVRN net income for the last year is -20.6M USD.
How many employees does Innoveren Scientific have?▼
As of April 01, 2026, the company has 8 employees.
In which sector is Innoveren Scientific located?▼
Innoveren Scientific operates in the Manufacturing sector.
When did Innoveren Scientific complete a stock split?▼
The last stock split for Innoveren Scientific was on June 13, 2022 with a ratio of 1:1000.